ReviewOncoTargets and therapy2016

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice.

Antonio Passaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.